FORVEL

This brand name is authorized in Austria, Cyprus, Estonia, Croatia, Lithuania, Malta, Romania

Active ingredients

The drug FORVEL contains one active pharmaceutical ingredient (API):

1 Naloxone UNII 5Q187997EE - NALOXONE HYDROCHLORIDE DIHYDRATE

Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine. Read about Naloxone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AB15	Naloxone	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1712898, 1712900
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083769, 1083770
Country: MT	Medicines Authority	Identifier(s): MA032/10601
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64182001, W64182002